lenvatinib

Open Access
Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma
NORIKAZU TANABE, ISSEI SAEKI, KENJI YAMAOKA, TOMOKAZU KAWAOKA, TETSU TOMONARI, JOJI TANI, TAKESHI TERASHIMA, YUSUKE KAWAMURA, SHIRO OKA, TETSUJI TAKAYAMA, HIDEKI KOBARA, TARO YAMASHITA, NORIO AKUTA, TAKAHIRO YAMASAKI and TARO TAKAMI

Anticancer Research March 2025, 45 (3) 1117-1125; DOI: https://doi.org/10.21873/anticanres.17499
Open Access
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice
AKIKO TATEISHI, YUSUKE OKUMA, YASUSHI GOTO, MOTOKO ARAKAKI, YUKIKO SHIMODA IGAWA, MASAHIRO TORASAWA, YUKI SHINNO, TATSUYA YOSHIDA, HIDEHITO HORINOUCHI, NOBORU YAMAMOTO and YUICHIRO OHE

Anticancer Research December 2024, 44 (12) 5501-5513; DOI: https://doi.org/10.21873/anticanres.17376
You have access
Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
KUNIHIDE MOHRI, HIDENARI NAGAI, TAKAHISA MATSUDA, YOSHINORI IGARASHI and KOJI HIGAI

Anticancer Research September 2024, 44 (9) 3919-3929; DOI: https://doi.org/10.21873/anticanres.17220
You have access
Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
TAKAFUMI YAMAMOTO, TAKANORI ITO, KAZUYUKI MIZUNO, SHINYA YOKOYAMA, KENTA YAMAMOTO, NORIHIRO IMAI, YOJI ISHIZU, TAKASHI HONDA and HIROKI KAWASHIMA

Anticancer Research September 2024, 44 (9) 4101-4111; DOI: https://doi.org/10.21873/anticanres.17239
You have access
Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma
SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUYA MIMURA, AKIHIRO MINAMI, KENJI MOMOSE, HIROTAKA HIRANO, MOTOFUMI TANAKA, YUKI UEDA, KENTARO TAI, YUKI YASUHARA, DAISUKE NAKAGAWA, ATSUSHI YAMAMOTO, MASAHIRO KIDO, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO

Anticancer Research July 2024, 44 (7) 3097-3103; DOI: https://doi.org/10.21873/anticanres.17123
You have access
Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab
CHIKA NAGAHISA, KAZUHIKO YOSHIDA, HANAE KONDO, TAKAYUKI NAKAYAMA, SHINSUKE MIZOGUCHI, RYO MINODA, HIRONORI FUKUDA, YUKI KOBARI, JUNPEI IIZUKA, YOJI NAGASHIMA, HIDEKI ISHIDA and TOSHIO TAKAGI

Anticancer Research March 2024, 44 (3) 1317-1321; DOI: https://doi.org/10.21873/anticanres.16927
You have access
Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells
CHUN-YI LI, HSIN-CHUAN CHEN, CHIH-YING LIAO, FEI-TING HSU, KUANG-CHEN HUNG, KUO-CHING LIU, JAW-CHYUN CHEN and MING-CHOU KU

Anticancer Research January 2024, 44 (1) 85-92; DOI: https://doi.org/10.21873/anticanres.16790
Open Access
Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma
HISANORI MUTO, TEIJI KUZUYA, NAOTO KAWABE, EIZABURO OHNO, KOHEI FUNASAKA, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, RYOJI MIYAHARA, TOMOYUKI SHIBATA, SENJU HASHIMOTO, YOSHIAKI KATANO and YOSHIKI HIROOKA

Anticancer Research October 2023, 43 (10) 4673-4682; DOI: https://doi.org/10.21873/anticanres.16663
You have access
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO and TORU IKEGAMI

Anticancer Research April 2023, 43 (4) 1761-1766; DOI: https://doi.org/10.21873/anticanres.16329
You have access
ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma
DAICHI ENOMOTO, KAZUHIRO YAMAMOTO, YUKI MATSUMOTO, ASAMI MORIOKA, TOMOHIRO OMURA, SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUMI FUKUMOTO and IKUKO YANO

Anticancer Research March 2023, 43 (3) 1317-1323; DOI: https://doi.org/10.21873/anticanres.16279

Main menu

User menu

Search

lenvatinib

Pages